PharmiWeb2h
Calquence plus chemoimmunotherapy recommended for approval in the EU by CHMP as first and only BTK inhibitor for 1st-line mantle cell lymphoma
AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been recommended for approval in the European Union (EU) for the treatment of adult patients with previously ...
AstraZeneca makes regulatory progress with Imfinzi, Calquence
AstraZeneca announced on Monday that it secured a US regulatory approval and a positive EU recommendation for two of its ...
London pre-open: Stocks to fall amid tariff concerns
London stocks were set to fall at the open on Monday following heavy losses in Asia, with Donald Trump’s tariffs due to kick ...
AstraZeneca reports positive developments with assets in US and EU
(Alliance News) - AstraZeneca PLC on Monday detailed progress with two of its drugs as it reported an endorsement in the EU and an approval in the US.
CORRECT: AB Foods says Primark CEO leaves after investigation
In early UK corporate news AB Foods said the boss of Primark has left the position after an investigation into his conduct. Aston Martin announced Executive Chair Lawrence Stroll's Yew Tree Consortium ...